Intercept Pharmaceuticals Inc EV/EBIT
Qual é o EV/EBIT de Intercept Pharmaceuticals Inc?
O EV/EBIT de Intercept Pharmaceuticals Inc é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Intercept Pharmaceuticals Inc
O que Intercept Pharmaceuticals Inc faz?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas com ev/ebit semelhantes a Intercept Pharmaceuticals Inc
- Country Club Hospitality & Holidays tem EV/EBIT de N/A
- AF2 Capital tem EV/EBIT de N/A
- Relmada Therapeutics Inc tem EV/EBIT de N/A
- Emerge Commerce tem EV/EBIT de N/A
- Bank of Marin Bancorp tem EV/EBIT de N/A
- Vita 34 AG tem EV/EBIT de N/A
- Intercept Pharmaceuticals Inc tem EV/EBIT de N/A
- Raminfo tem EV/EBIT de N/A
- Perceptron tem EV/EBIT de N/A
- Suven Life Sciences tem EV/EBIT de N/A
- Morarjee Textiles tem EV/EBIT de N/A
- Crinetics Pharmaceuticals Inc tem EV/EBIT de N/A
- Ramky Infrastructure tem EV/EBIT de N/A